专题 |
|
|
|
|
英国生物技术成果转化经验及若干启示 |
张大璐 |
中国生物技术发展中心 北京 |
|
Experience of British Biotechnology Achievements Transformation and Suggestions |
ZHANG Da-lu |
China National Center for Biotechnology Development |
[1] 赵清华,范明杰,李玉洁,等. 英国:10%的GDP受益于生物技术应用. 中国生物工程杂志,2008, 28(7):2-5. Zhao Q H, Fan M J, Li Y J, United Kingdom:10 percent of GDP to benefit from biotechnology applications. China Biotechnology, 2008, 28 (7):2-5. [2] Geoffrey O. Entrepreneurship in UK biotechnology: the role of public policy. The Diebold Institute Entrepreneurship and Public Policy Project,2001,14:6-28. [3] Charlotte B. How and when did we get here? an historical institutionalist analysis of EU biotechnology policy. Journal of European Integration, 2011, 34(4):341-357 [4] 李志军. 英国技术集团(BTG)的技术转移. 调查研究报告,2003,52: 1-17. Li Z J. British Technology Group (BTG) technology transfer. Research Reports, 2003,52: 1-17. [5] 孟胜利. 英国生物技术产业的最新进展. 生物技术世界, 2008,6:5-9. Meng S L. The latest progress of the British biotechnology industry. The World of Biotechnology, 2008,6:5-9. [6] Henderson R, Orsenigo L, Pisano G. The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions Between Scientific, Institutional and Organizational Change in The Sources of Industrial Advantages. Cambridge: Cambridge University Press, 1999. 10-18, 24-35, 52-68. [7] Calin Gurau, Leo-Paul Dana, el al. Academic entrepreneurship in UK biotechnology firms: alternative models and the associated performance. Journal of Enterprising Communities: People and Places in the Global Economy, 2012,6(2):154-168. [8] Cockburn I, Henderson R. Public-private interaction in pharmaceutical research. Proc Natl Acad Sci USA, 1996, 93:12725-12730. [9] Goldman M. Industrial biotechnology in the UK: a funder’s perspective Goldman Merlin. Industrial Biotechnology, 2011, 7(4): 269-271. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|